Abstract
Aim. This study was conducted to assess the awareness of dentists about the questions of pharmacokinetics and pharmacodynamics of nonsteroidal anti-inflammatory drugs as well as to study the features of their use for the relief of pain syndrome in dental practice.Materials and methods. By means of the questionnaires were studied 107 dentists working in dental clinics and dental departments of General hospitals, especially their use of the nonsteroidal anti-inflammatory drugs for pain relief.Results. It was determined that 85% of doctors use non-selective and moderately selective cyclooxygenase inhibitors (COX), 15%-prefer Cox-2 inhibitor with the pronounced selectivity for pain relief. The highest number of correct answers was given by a group of doctors with work experience from 5 to 10 years (40.3%), the lowest – by doctors with work experience more than 20 years, respectively 40.3% and 36.1% of the total number of doctors from the studied groups.Conclusion. There was noted that it is necessary to pay attention to the peculiarities of pain relief for the improvement of dentists’ work as well as to involve clinical pharmacologists for these purposes.
Highlights
Aim This study was conducted to assess the awareness of dentists about the questions of pharmacokinetics and pharmacodynamics of nonsteroidal anti-inflammatory drugs as well as to study the features of their use for the relief of pain syndrome in dental practice
By means of the questionnaires were studied 107 dentists working in dental clinics and dental departments of General hospitals, especially their use of the nonsteroidal anti-inflammatory drugs for pain relief
It was determined that 85% of doctors use non-selective and moderately selective cyclooxygenase inhibitors (COX), 15%-prefer Cox-2 inhibitor with the pronounced selectivity for pain relief
Summary
Оценить осведомленность врачей-стоматологов в вопросах фармакокинетики и фармакодинамики нестероидных противовоспалительных средств, а также изучить особенности применения ими нестероидных противовоспалительных средств для купирования болевого синдрома в стоматологической практике. Путём анкетирования 107 врачей-стоматологов, работающих в отделениях стоматологических поликлиник и стоматологических отделениях многопрофильных стационаров, изучены особенности применения ими нестероидных противовоспалительных препаратов для купирования болевого синдрома. Установлено, что 85% врачей для купирования болевого синдрома используют неселективный и умеренно селективный ингибиторы циклооксигеназы (ЦОГ), 15% – отдают предпочтение ингибитору ЦОГ-2 с выраженной селективностью. Отмечена необходимость при усовершенствовании врачей-стоматологов уделять внимание особенностям купирования болевого синдрома в стоматологической практике и привлекать для этих целей клинических фармакологов.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
